What is Macular Degeneration? - AMDF
Macular Degeneration, also known as Age-related Macular Degeneration (AMD), is the leading cause of irreversible vision loss in adults over 60, affecting nearly 20 million Americans. The risk of developing AMD increases with age.
About Macular Degeneration - Symptoms, Risks, and Diagnosis
Macular degeneration is a progressive eye disease that affects the tiny, central part of the retina called the macula at the back of the eye and can cause loss of central vision. It is the leading cause of vision loss in people over 40.
The American Macular Degeneration Foundation (AMDF)
Here to help you learn about and live with Age-related Macular Degeneration (AMD), offering you healthy living tips, the latest information, and ways to honor those touched by macular disease, while supporting researchers working to prevent, treat and cure macular degeneration and Stargardt disease.
Learn About Types and Stages of Macular Degeneration
Learn more about Wet Macular Degeneration. Stages of macular degeneration. There are four stages of AMD, defined by physical and/or functional changes to the retina, the macula, and underlying structures. Sub-clinical AMD — Loss of Dark Adaptation
Macular Degeneration Overview | Quick Summary by AMDF
Macular degeneration is caused by deterioration of a a critical portion of the retina, which is the tissue that lines the back of the eye and translates light from the images we see into electrical impulses, which are sentt via the optic nerve to the brain, which interprets them as sight.
Macular Degeneration Treatments - Learn About Your Options
Currently, the most common and effective clinical treatment for wet Age-related Macular Degeneration is anti-VEGF therapy – which is periodic intravitreal (into the eye) injection of a chemical called an “anti-VEGF.”
Free Amsler Grid from The American Macular Degeneration …
Free, printable amsler grid to monitor your vision for changes with macular degeneration. Provided by The American Macular Degeneration Foundation..
Category: Macular Degeneration Research Advances
NORTHAMPTON, Ma., Dec. 19, 2023 — The American Macular Degeneration Foundation received news that the first patient has been dosed in a safety and efficacy clinical trial of a one-time gene therapy treatment for advanced dry macular degeneration (dry AMD), also known as Geographic Atrophy (GA).
Medication Cautions in Macular Degeneration - AMDF
A list of medications to use with caution if you have macular degeneration, compiled by the National Registry of Drug-Induced Ocular Side Effects.
Donate to the American Macular Degeneration Foundation
Donate today to support macular degeneration education, research, awareness, and advocacy and improve the lives of those impacted by macular degeneration.